Yungjin Pharm. Co., Ltd. Stock: price and insider trades · South Korea
영진약품
Yungjin Pharm. Co., Ltd.: what insiders have been doing
This page follows insider dealings at Yungjin Pharm. Co., Ltd. as filed with DART (FSS), a company from the Health Care sector. In the past year (31 October 2025 to 31 October 2026), 2 filings came from 1 insider.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Over the last twelve months, not one insider purchase of Yungjin Pharm. Co., Ltd. stock was filed.
Compared with its exchange (2,655 companies, median 7 filings), a count of 2 filings is below the norm.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
7 of 7 declarations
About Yungjin Pharm. Co., Ltd.
영진약품 is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the research, development, and manufacturing of pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations